NYSE:CLVTProfessional Services
Clarivate (CLVT) Valuation Check After Nissan IPfolio Win, Drugs To Watch Release And Analyst Downgrade
Clarivate (CLVT) has been in focus after Nissan selected its IPfolio software and the company published its 2026 Drugs to Watch report. At the same time, a recent downgrade raised questions about growth and competitive pressures.
See our latest analysis for Clarivate.
Against the backdrop of Nissan’s IPfolio adoption and the latest Drugs to Watch publication, Clarivate’s recent share price returns show limited momentum. A 30-day share price return of 6.35% decline and a 1-year total...